Home Department: undeclared
Mentor: Jonathan Pollack, Pathology

In prostate cancer, a key clinical need is distinguishing those cancers that need to be treated from those that do not. The current best indicator is tumor grade, i.e. how disorganized the tumor appears under the microscope. Noah’s studies aim to understand the molecular basis for low versus high grade prostate cancer, with implications for new biomarkers of tumor aggressiveness that will help to better determine who to treat, and possibly find new avenues for prevention and treatment.